Roche Analyst Event at ASCO 2015

Analyst briefing on data presented at ASCO: Sunday, 31 May 2015 6:45 PM CDT

Webcast

Agenda

• Oncology strategy and outlook
  Daniel O'Day, Chief Operating Officer Roche Pharmaceuticals
• Working along the cancer immunity-cycle: Strategies and new agents
  Ira Mellman, gRED: Ph.D., Vice President, Cancer Immunology, Genentech
  William Pao, pRED: M.D., Ph.D., Global Head Oncology Discovery and Translational Area, Roche
• ASCO 2015 Roche highlights: Setting new standards, developing combinations
  Sandra Horning, M.D., Chief Medical Officer and Head Global Product Development
• Growing importance of molecular information in cancer immunotherapy
  Garret Hampton, Ph.D., Vice President, Oncology Biomarker Development and Companion Diagnostics